BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14557455)

  • 21. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution patterns of matrix metalloproteinase (MMP)-2 and -9 and their inhibitors (TIMP-1 and TIMP-2) in the human decidua during early pregnancy.
    Seval Y; Akkoyunlu G; Demir R; Asar M
    Acta Histochem; 2004; 106(5):353-62. PubMed ID: 15530550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells.
    Korem S; Resnick MB; Kraiem Z
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3322-7. PubMed ID: 10487706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the motility of human decidual endometrial stromal cells: possible effect on embryo implantation and pregnancy.
    Wu HM; Huang HY; Lee CL; Soong YK; Leung PC; Wang HS
    Biol Reprod; 2015 Apr; 92(4):98. PubMed ID: 25761596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
    Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
    J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Homocysteine decreases the invasion in cultured human trophoblasts: relationship between homocysteine and matrix metalloproteinase-2, -9 expression].
    Yang PF; Li JK; Xiong Q
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):184-6. PubMed ID: 17537305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes.
    He S; Prasanna G; Yorio T
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3737-45. PubMed ID: 17652746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas.
    Zhang X; Wang Y; Yamamoto G; Tachikawa T
    Histopathology; 2009 Sep; 55(3):250-60. PubMed ID: 19723139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways.
    Liu J; Maccalman CD; Wang YL; Leung PC
    Mol Endocrinol; 2009 Jul; 23(7):1014-21. PubMed ID: 19372239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse.
    Wang X; Li Y; Chen J; Guo X; Guan H; Li C
    Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.
    Canning MT; Postovit LM; Clarke SH; Graham CH
    Exp Cell Res; 2001 Jul; 267(1):88-94. PubMed ID: 11412041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-10 may participate in regulating trophoblast invasion in human placentae throughout gestation.
    Pang ZJ; Zhou JG; Huang LP
    Am J Reprod Immunol; 2008 Jul; 60(1):19-25. PubMed ID: 18593434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 3,5,3'-triiodothyronine on the invasive potential and the expression of integrins and matrix metalloproteinases in cultured early placental extravillous trophoblasts.
    Oki N; Matsuo H; Nakago S; Murakoshi H; Laoag-Fernandez JB; Maruo T
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5213-21. PubMed ID: 15472228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of recombinant H2 relaxin on the expression of matrix metalloproteinases and tissue inhibitor metalloproteinase in cultured early placental extravillous trophoblasts.
    Maruo N; Nakabayashi K; Wakahashi S; Yata A; Maruo T
    Endocrine; 2007 Dec; 32(3):303-10. PubMed ID: 18236174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.